ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PROK ProKidney Corporation

3.50
-0.10 (-2.78%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 298,572
Bid Price 3.00
Ask Price 3.50
News -
Day High 3.60

Low
1.12

52 Week Range

High
13.51

Day Low 3.14
Share Name Share Symbol Market Stock Type
ProKidney Corporation PROK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.10 -2.78% 3.50 17:25:32
Open Price Low Price High Price Close Price Previous Close
3.57 3.14 3.60 3.19 3.60
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,319 298,572 US$ 3.35 US$ 998,824 - 1.12 - 13.51
Last Trade Type Quantity Price Currency
17:11:58 formt 150 US$ 3.50 USD

ProKidney Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.18B 235.43M - 0 -35.47M -0.15 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ProKidney News

Date Time Source News Article
6/03/202415:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/31/202415:19Edgar (US Regulatory)Form 8-K - Current report
5/29/202406:04Edgar (US Regulatory)Form 8-K - Current report
5/22/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/20/202415:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/10/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/10/202406:05Edgar (US Regulatory)Form 8-K - Current report
3/05/202415:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/12/202415:05Edgar (US Regulatory)Form 8-K - Current report
2/06/202415:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PROK Message Board. Create One! See More Posts on PROK Message Board See More Message Board Posts

Historical PROK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.224.25753.003.39588,575-0.72-17.06%
1 Month2.654.442.603.74786,7400.8532.08%
3 Months1.384.441.352.68800,1782.12153.62%
6 Months1.804.441.182.18698,3731.7094.44%
1 Year11.9013.511.123.50698,074-8.40-70.59%
3 Years9.4014.191.124.49425,612-5.90-62.77%
5 Years9.4014.191.124.49425,612-5.90-62.77%

ProKidney Description

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.

Your Recent History

Delayed Upgrade Clock